Marketing-authorisation holder · United States
Recordati Rare
12 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · United States
12 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
12 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| CARBAGLU200mg · Tablet, for suspension | Carglumic acid | United States | Marketed | 2010 |
| CHEMET100mg · Capsule | Technetium (99m tc) succimer | United States | Marketed | 1991 |
| COSMEGEN0.5MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Dactinomycin | United States | Not marketed | 1964 |
| CYSTADANE1gm/scoopful · For solution | Betaine | United States | Marketed | 1996 |
| CYSTADROPS0.37% base · Solution/drops | Mercaptamine | United States | Marketed | 2020 |
| INDOCIN1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Injectable | Indometacin | United States | Not marketed | 1985 |
| ISTURISA10mg base | 1mg base | 5mg base · Tablet | Osilodrostat | United States | Marketed | 2020 |
| MUSTARGEN10mg/vial · Injectable | Chlormethine | United States | Not marketed | 1949 |
| NEOPROFEN20mg base/2ml (eq 10mg base/ml) · Injectable | Ibuprofen | United States | Marketed | 2006 |
| PEGANONE250mg | 500mg · Tablet | Ethotoin | United States | Not marketed | 1957 |
| SIGNIFOR0.3mg base/ml (eq 0.3mg base/ml) | 0.6mg base/ml (eq 0.6mg base/ml) | 0.9mg base/ml (eq 0.9mg base/ml) · Solution | Pasireotide | United States | Marketed | 2012 |
| SIGNIFOR LAR KIT10mg base/vial | 20mg base/vial | 30mg base/vial | 40mg base/vial | 60mg base/vial · For suspension | Pasireotide | United States | Marketed | 2014 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 12 | 12 | 0 | CompaniesAll medicines |
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.